Matthew Osborne

Matthew Osborne

No más puestos en curso
Health Technology
Finance
Consumer Services

Perfil

Mr. Matthew S.
Osborne
was previously employed as an Investor Relations by Apple Tree Venture Management Llc//vc, a Chief Financial Officer by Senda Biosciences, Inc., a Chief Financial Officer by Oncxerna Therapeutics, Inc., a Chief Financial Officer by Unum Therapeutics, Inc., a Chief Financial Officer by Unum Therapeutics, Inc., a VP-Investor Relations & Corporate Communications by Voyager Therapeutics, Inc., a Head-Investor Relations by Shire Plc, a Vice President-Investor Relations by Synageva BioPharma Corp., a Vice President by FM Partners Holdings LLC, an Associate Analyst by SVB Securities LLC, a Vice President by C.
E.
Unterberg, Towbin, Inc., a Salesman by Genzyme Corp., and a Head-Investor Relations by Vertex Pharmaceuticals, Inc. He received his undergraduate degree from Syracuse University and an MBA from D'Amore-Mckim School of Business.

Antiguos cargos conocidos de Matthew Osborne.

EmpresasCargoFin
Public Communications Contact 31/08/2024
Director Financiero/CFO 01/10/2022
Director Financiero/CFO 01/06/2021
COGENT BIOSCIENCES, INC. Director Financiero/CFO 01/06/2020
COGENT BIOSCIENCES, INC. Director Financiero/CFO 29/05/2020
Ver el detalle de la experiencia de Matthew Osborne.

Formación de Matthew Osborne.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

75

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Finance

Finance

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology